-
General overview of the MDR and IVDR and their importance On 26 May 2021, the regulatory framework for medical devices will change significantly. Although Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices (MDR) and Regulation (EU) 2017/746 of the European Parliament and of the Council […]
-
In this newsflash, you will find our overview of the COVID-19 vaccine development, accessibility and legal aspects, as well as an update on the new pharmaceutical strategy for Europe and other relevant news. Our Life Sciences & Healthcare team is at your disposal should you need any advice on issues you are facing. COVID-19 […]
-
With the rapid development of pharmaceuticals and new medical procedures, the liability of those involved in patient treatment is becoming a subject of serious discussion. In this newsflash you will find our view of the current situation in our countries, as well as suggestions as to what should be improved and clarified in the interests […]
-
Remote doctor’s appointments and consulting services allowed but unregulated The Estonian Health Insurance Fund (the HIF) enabled remote consulting services during the state of emergency. At the moment, however, remote appointments are not regulated by legal acts. The HIF hopes to add remote appointments to the list of health care services no later than by […]
-
Our Life Sciences & Healthcare team has prepared a summary of measures adopted up to April 14 2020 in Estonia specifically targeted at Life Sciences companies. A draft law is currently pending in the Estonian parliament which foresees many changes to the law due to the Covid-19 crisis. Among others, the Medicinal Products Act is […]
